# Corinne Faivre-Finn

Source: https://onco.cc/people/corinne-faivre-finn/  
OnCo record `corinne-faivre-finn` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Led CONVERT, which set the radiotherapy schedule for limited-stage small-cell lung cancer.

## Summary

Corinne Faivre-Finn was chief investigator of CONVERT, the international trial that compared twice-daily and once-daily thoracic radiotherapy in limited-stage SCLC and confirmed twice-daily 45 Gy as the standard. She co-leads studies of radiotherapy-immunotherapy combinations in the PACIFIC and ADRIATIC era and the Christie's thoracic radiotherapy research group.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: radiotherapy; sclc
- Role: Professor of Thoracic Radiation Oncology, University of Manchester and The Christie
- Specialisms: Small-cell lung cancer radiotherapy; Thoracic radiotherapy; Radiotherapy-immunotherapy combinations; Real-world data

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Faivre-Finn%20C%5BAuthor%5D%20small-cell%20radiotherapy

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- institutions: [The Christie NHS Foundation Trust](https://onco.cc/institutions/the-christie/)
- trials: [ADRIATIC](https://onco.cc/trials/adriatic/), [CONVERT](https://onco.cc/trials/convert/)
- key papers: [ADRIATIC: durvalumab after chemoradiotherapy for limited-stage small-cell lung cancer](https://onco.cc/key-papers/paper-adriatic-nejm-2024/)
- journals: [Journal of Thoracic Oncology](https://onco.cc/journals/journal-of-thoracic-oncology/)
- people: [Alastair Greystoke](https://onco.cc/people/alastair-greystoke/), [Sanjay Popat](https://onco.cc/people/sanjay-popat/)

---
JSON: https://onco.cc/api/v1/entities/corinne-faivre-finn.json